a:5:{s:8:"template";s:12592:"<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8"/>
<title>{{ keyword }}</title>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<meta content="width=device-width,initial-scale=1.0" name="viewport"/>
<link href="http://fonts.googleapis.com/css?family=Yanone+Kaffeesatz:400,700" rel="stylesheet" type="text/css"/>
<link href="http://fonts.googleapis.com/css?family=Oswald" rel="stylesheet" type="text/css"/>
<style rel="stylesheet" type="text/css">@charset "utf-8";body,div,footer,form,h1,h2,h3,header,html,img,li,nav,p,span,time,ul{margin:0;padding:0;border:0;outline:0;font-size:100%;vertical-align:baseline;background:0 0}body{line-height:1}footer,header,nav{display:block}nav ul{list-style:none}a{margin:0;padding:0;font-size:100%;vertical-align:baseline;background:0 0}a{margin:0;padding:0;font-size:100%;vertical-align:baseline;background:0 0}input{vertical-align:middle}#sb-site,.sb-slidebar,body,html{margin:0;padding:0;-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}body,html{width:100%;overflow-x:hidden}html{height:100%}body{min-height:100%;height:auto;position:relative}#sb-site{width:100%;position:relative;z-index:1}.sb-slidebar{height:100%;overflow-y:auto;position:fixed;top:0;z-index:0;display:none;background-color:#fff;-webkit-transform:translate(0)}.sb-right{right:0}.sb-slidebar{width:30%}@media (max-width:480px){.sb-slidebar{width:70%}}@media (min-width:481px){.sb-slidebar{width:55%}}@media (min-width:768px){.sb-slidebar{width:40%}}@media (min-width:992px){.sb-slidebar{width:30%}}@media (min-width:1200px){.sb-slidebar{width:20%}}#sb-site,.sb-slidebar{-webkit-transition:-webkit-transform .4s ease;-moz-transition:-moz-transform .4s ease;-o-transition:-o-transform .4s ease;transition:transform .4s ease;-webkit-transition-property:-webkit-transform,left,right;-webkit-backface-visibility:hidden} @font-face{font-family:'Yanone Kaffeesatz';font-style:normal;font-weight:700;src:url(http://fonts.gstatic.com/s/yanonekaffeesatz/v14/3y9I6aknfjLm_3lMKjiMgmUUYBs04aUXNxt9gW2LIftoEdKZd2GP.ttf) format('truetype')}body{margin:0;font-family:'Century Gothic',Helvetica,Arial,Sans-serif;font-size:14px;line-height:20px;text-align:left;vertical-align:top;background:#fff;color:#000}body,form,h1,h2,h3,p{margin:0;padding:0}h1{font-size:24px;padding:0 0 10px 0}a:link,a:visited{text-decoration:none;color:#ef717d}a:hover{color:#f28b2e}p{padding:0 0 10px}.clear{clear:both}#sb-site{}#wrapper{background:#fff;margin:0 auto 0 auto;max-width:1000px;text-align:left;width:100%}#innerWrap{padding:0 30px;width:auto}#mainHd{min-height:163px;width:100%}#mainHd h1{float:left;height:163px;margin:0;text-indent:-9999px;width:234px}#mainHd h1 a{display:block;height:163px;width:234px}#mainHd .menu{border-top:6px double #999b9a;border-bottom:6px double #999b9a;float:right;font-family:'Yanone Kaffeesatz';font-size:44px;font-weight:700;line-height:44px;list-style:none;margin:25px 0 10px;padding:5px 0;max-width:706px;text-transform:uppercase;width:auto}#mainHd .menu li{float:left;list-style:none;position:relative}#mainHd .menu li a{padding:0 12px}#mainHd .menu li ul{display:none;position:absolute;top:44px;left:0;width:180px;background:#fff;box-shadow:0 0 4px #606060;z-index:99}#mainHd .menu li:hover ul{display:block}#mainHd .menu li ul li{float:none;font-size:24px;line-height:24px;margin:0;padding:0}#mainHd .menu li ul li a{display:block;padding:10px 0 10px 15px}#mainHd .menu li:nth-child(6n-5) a{color:#ef7163}#mainHd .menu li:nth-child(6n-5) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-4) a,#mainHd .menu li:nth-child(6n-4) ul li a{color:#ef717d}#mainHd .menu li:nth-child(6n-4) a:hover,#mainHd .menu li:nth-child(6n-4) ul li a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-3) a{color:#f49081}#mainHd .menu li:nth-child(6n-3) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-2) a{color:#f28b2e}#mainHd .menu li:nth-child(6n-2) a:hover{color:#999b9a}#mainHd .menu li:nth-child(6n-1) a{color:#fac829}#mainHd .menu li:nth-child(6n-1) a:hover{color:#999b9a}  .menu{border-top:1px solid #ccc;clear:both;font-family:'Yanone Kaffeesatz';font-size:30px;font-weight:700;line-height:30px;list-style:none;padding-top:5px;text-align:right;text-transform:uppercase}.sb-slidebar .menu li{border-bottom:1px solid #ccc;padding:0 0 5px;margin-bottom:5px}.sb-slidebar .menu ul{list-style:none;padding-top:5px}.sb-slidebar .menu ul li{border-bottom:none;font-size:24px;line-height:24px;padding:0 0 0;font-weight:400}.sb-slidebar .menu ul li a{color:#7bd3c7}.sb-slidebar .menu ul li a:hover{color:#5fbbb6}.sb-toggle-right{display:none;cursor:pointer;float:right;margin:0;padding-top:30px;width:25px}.sb-toggle-right .navicon-line{background:#ef717d;display:block;height:5px;margin:0 auto 5px;width:25px}.sb-toggle-right:hover .navicon-line{background:#5fbbb6}#mainFoot{background:#f49081;box-sizing:border-box;clear:both;color:#fff;padding:30px 2% 0 2%;width:100%}#leftFt{box-sizing:border-box;float:left;max-width:470px;padding-right:15px;width:50%}#leftFt #ftNav .menu{color:#fff;list-style:none;float:left;border-top:6px double #fff;border-bottom:6px double #fff;font-family:'Yanone Kaffeesatz';font-size:22px;font-weight:700;line-height:22px;padding:5px 0;margin-bottom:15px;text-transform:uppercase;width:100%}#leftFt #ftNav .menu li{float:left;padding:2px 5px 2px 0;border-right:3px solid #fff;margin-right:5px}#leftFt #ftNav .menu li:last-child{padding-right:0;border-right:none;margin-right:0}#leftFt #ftNav .menu li a{color:#fff}#leftFt #ftNav .menu li a:hover{color:#f8d4cf}#leftFt .socialIcons{color:#f8d4cf;font-family:'Yanone Kaffeesatz';font-size:28px;font-weight:700;line-height:28px;list-style:none;float:left;height:33px;text-transform:uppercase;vertical-align:bottom;width:410px}#leftFt .socialIcons::before{content:"DON'T BE ANTI-SOCIAL:"}#leftFt .socialIcons li a{background-position:center bottom;background-repeat:no-repeat;display:block;height:32px;width:32px}#leftFt .socialIcons li a:hover{background-position:center top}#rightFt{box-sizing:border-box;float:right;max-width:470px;padding-left:15px;width:50%}#rightFt::after{clear:both}#rightFt #bioPic{box-sizing:border-box;float:right;height:169px;margin:0 0 10px 15px;padding:5px;width:147px}#rightFt #bioPic img{height:auto;max-width:100%}#rightFt h3{color:#fff;font-family:havana;font-size:57px;font-weight:400;line-height:57px}#rightFt h3 span{color:#fac829}#mainFoot p{line-height:18px}p.copy{clear:both;color:#fff;font-size:10px;line-height:12px;margin:0;padding:10px 0 0}.copy a{color:#606060}.copy a:hover{color:#fff}#slider{margin-bottom:30px}#recBlog{background:#f7f5ef box-sizing:border-box;padding:20px 20px 40px;margin-bottom:20px;float:right;min-height:272px;width:74%}#recBlog h2{color:#ef717d;font-family:'Yanone Kaffeesatz';font-size:34px;font-weight:700;line-height:34px;margin:0 0 5px;padding:0;text-transform:uppercase;width:100%}#recBlog p.date{font-size:12px;line-height:16px}#recBlog .more{color:#fff;float:right;font-family:'Yanone Kaffeesatz';font-size:26px;font-weight:700;line-height:26px;text-transform:uppercase}#recBlog .more a{background:#ef717d;color:#fff;display:block;padding:5px 10px;width:auto}#recBlog .more a:hover{background:#f28b2e}#newsletter{background:#ef717d;box-sizing:border-box;color:#fff;float:left;margin-bottom:20px;padding:20px 20px 50px;width:24%}#newsletter h2{font-family:havana;font-size:48px;font-weight:400;line-height:48px;margin:0;padding:0}#newsletter h3{font-family:'Yanone Kaffeesatz';font-size:24px;line-height:24px;margin:0 0 15px;text-align:right;text-transform:uppercase}#newsletter input[type=email],#newsletter input[type=text]{background:#f799a2;border:none;box-sizing:border-box;height:32px;margin-bottom:10px;padding:5px 10px;width:100%}#newsletter input[type=submit]{background:#fac829;border:none;color:#fff;font-family:'Yanone Kaffeesatz';font-size:26px;font-weight:700;float:right;letter-spacing:normal;line-height:26px;padding:5px 10px;text-transform:uppercase;width:auto}#newsletter input[type=submit]:hover{background:#b1e2dc}#pco,#shco{box-sizing:border-box;float:left;padding-bottom:40px;width:50%}#pco{padding-right:10px}#pco h3{border-top:6px double #999b9a;border-bottom:6px double #999b9a;color:#f28b2e;font-family:'Yanone Kaffeesatz';font-family:havana;font-size:44px;font-weight:400;line-height:44px;margin:0 0 15px;padding:5px 0;text-align:center;width:100%}#shco{padding-left:10px}#shco h3{border-top:6px double #999b9a;border-bottom:6px double #999b9a;color:#5fbbb6;font-family:havana;font-size:44px;font-weight:400;line-height:44px;margin:0 0 15px;padding:5px 0;text-align:center;width:100%}.releaseBlock{box-sizing:border-box;max-width:320px;float:left;height:auto;margin:0;padding:10px;width:50%}.releaseBlock img{height:auto;max-width:100%}input[type=email]{background:#d8d8d8;border:none;box-sizing:border-box;height:40px;margin:0 0 15px;padding:10px 15px;width:100%}::-webkit-input-placeholder{color:#fff}:-moz-placeholder{color:#fff}::-moz-placeholder{color:#fff}:-ms-input-placeholder{color:#fff}.rslides{box-sizing:border-box;position:relative;list-style:none;width:100%;padding:0;margin:0;z-index:0}.rslides li{-webkit-backface-visibility:hidden;position:absolute;display:none;width:100%;left:0;top:0;z-index:0}.rslides li:first-child{position:relative;display:block;float:left}.rslides img{display:block;height:auto;float:left;width:100%;border:0}@media screen and (max-width:960px){#sb-site{background:#fff}#wrapper{padding:0;width:100%}#innerWrap{padding:0 5%;width:90%}#mainHd .menu{font-size:30px;line-height:30px}}@media screen and (max-width:865px){#mainHd{margin-bottom:20px}#mainHd h1{float:none;margin:0 auto}#mainHd .menu{float:left;font-size:44px;line-height:44px;margin:10px auto;max-width:100%;width:100%}#mainHd .menu li:last-child::after{clear:both}#mainHd .socialIcons{padding:0}}@media screen and (max-width:768px){#mainHd h1{float:left;margin:0}#mainHd #searchform,#mainHd .menu,#mainHd .socialIcons{display:none}.sb-toggle-right{display:block}#leftFt .socialIcons{display:none}#leftFt,#rightFt{float:none;margin:0 auto 20px;width:100%;max-width:100%}#newsletter,#recBlog{width:48%}#pco h3,#shco h3{font-size:30px;line-height:30px}.releaseBlock{float:none;margin:0 auto;width:100%}}@media screen and (max-width:480px){#newsletter,#recBlog{float:none;width:100%}#pco,#shco{float:none;padding:0 0 30px;width:100%}}@media only screen and (-webkit-min-device-pixel-ratio:2),only screen and (min--moz-device-pixel-ratio:2),only screen and (-o-min-device-pixel-ratio:2/1),only screen and (min-device-pixel-ratio:2){#mainHd h1{-webkit-background-size:234px 163px;-moz-background-size:234px 163px;-o-background-size:234px 163px;background-size:234px 163px} @font-face{font-family:Oswald;font-style:normal;font-weight:400;src:url(http://fonts.gstatic.com/s/oswald/v31/TK3_WkUHHAIjg75cFRf3bXL8LICs1_FvsUZiYA.ttf) format('truetype')}}</style>
</head>
<body>
<div id="sb-site">
<div id="wrapper">
<div id="innerWrap">
<header id="mainHd">
<h1>{{ keyword }}</h1>
<ul class="menu" id="menu-main-navigation-menu">
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-1995" id="menu-item-1995"><a href="#">{{ keyword }}</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page current_page_parent menu-item-1994" id="menu-item-1994"><a href="#">Blog</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-1998" id="menu-item-1998"><a href="#">About</a></li>
<li class="menu-item menu-item-type-taxonomy menu-item-object-category menu-item-1999" id="menu-item-1999"><a href="#">Tutorials</a></li>
</ul>
<div class="clear"></div>
</header>
{{ text }}
<p>.</p>
{{ links }}
</div>
<footer id="mainFoot">
<div id="leftFt">
<nav id="ftNav">
<ul class="menu" id="menu-footer-navigation-menu">
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2025" id="menu-item-2025"><a href="#">Terms of Use</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2015" id="menu-item-2015"><a href="#">Contact</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2027" id="menu-item-2027"><a href="#">Info</a></li>
<li class="menu-item menu-item-type-post_type menu-item-object-page menu-item-2014" id="menu-item-2014"><a href="#">Additional Services</a></li>
</ul> </nav>
<div class="clear"></div>
<p class="copy">{{ keyword }}</p>
</div>
<div id="rightFt">
<div id="bioPic"></div>
<h3>{{ keyword }}</h3>
</div>
<div class="clear"></div>
</footer>
</div>
</div>
</body>
</html>";s:4:"text";s:8644:"<p>(617) 582-8867Huiyun_Liu@dfci.harvard.edu, Projects: Genomics of Follicular Lymphoma, Signaling in Lymphoma (617) 582–9171. Based on these findings, we have opened a trial together with Gilead Sciences combining momelotinib with the MEK inhibitor trametinib in treatment refractory KRAS mutant lung cancer. David A. Barbie, MD - Medical Oncology. PCPs often are your first point of contact for your general health concerns. Projects: LLX Core // Experimental Therapeutics in T-cell Lymphomas, Project: Lymphoma research studies- 19-063 study, 16-570 MRD study and 16-570, Project: Novel Targets in T-cell Lymphomas, Focus: Drug Resistance and Novel Targets in T-Cell Lymphomas </p> <p>Translational Oncology/KRAS Targeted Therapy. Others have found that inhibition of the NF-kB and STAT pathways, in which TBK1 is involved, also results in impaired tumor growth in KRAS-driven mouse lung cancer. - "Concierge Medicine" is a unique offering in which providers care for a limited population of patients. For more information about these cookies and the data collected, please refer to our Privacy Policy. His research focuses on computational cancer genomics, the application of new molecular profiling technologies to advance precision cancer medicine, and studying resistance to cancer therapeutics. </p> <p>Copyright 2020 Dana-Farber Cancer Institute
  All Rights Reserved. Please call the practice to find out if your plan is accepted. Recently, we discovered that a kinase inhibitor, momelotinib, inhibits TBK1 and JAK signaling and has activity in mouse models of Kras-driven lung cancer. NOTES: - "Affiliation" is the local physician organization to which the doctor belongs. Note: This provider may accept more insurance plans than shown. ... Risch A, Rennert G, Arnold S, Wu X, Melander O, Brunnström H, Le Marchand L, Liu G, Andrew A, Duell E, Kiemeney LA, Shen H, Haugen A, Johansson M, Grankvist K, Caporaso N, Woll P, Dawn Teare M ... Dana-Farber Cancer Institute 450 Brookline Avenue Boston, MA 02215 Get Directions. Dana-Farber Cancer Institute450 Brookline AvenueBoston, MA 02215Get Directions. This provider may accept more insurance plans than shown. </p> <p>(617) 417-7958Wenchao_Wu@dfci.harvard.edu, Focus: Novel Targets and Mechanisms in Lymphomas Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer. </p> <p>              - "Affiliation" is the local physician organization to which the doctor belongs. Sun R, Xu M, Li X, Gaynor S, Zhou H, Li Z, Bossé Y, Lam S, Tsao MS, Tardon A, Chen C, Doherty J, Goodman G, Bojesen SE, Landi MT, Johansson M, Field JK, Bickeböller H, Wichmann HE, Risch A, Rennert G, Arnold S, Wu X, Melander O, Brunnström H, Le Marchand L, Liu G, Andrew A, Duell E, Kiemeney LA, Shen H, Haugen A, Johansson M, Grankvist K, Caporaso N, Woll P, Dawn Teare M, Scelo G, Hong YC, Yuan JM, Lazarus P, Schabath MB, Aldrich MC, Albanes D, Mak R, Barbie D, Brennan P, Hung RJ, Amos CI, Christiani DC, Lin X. Simon C. Mathews, MD. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. We use cookies and other tools to enhance your experience on our website and to analyze our web traffic. (617) 582 - 9630Shannonk_harkins@dfci.harvard.edu, Project: CAR-T 37, Nascent Transcriptomics, Profiling PDXs, Projects: Experimental Therapeutics in T-cell Lymphomas </p> <p>Specifically, I have focused on lung cancer clinically with a particular interest in targeting KRAS mutations, which have remained refractory to current therapies. </p> <p>"Near-term availability" is subject to change. My interest as a medical oncologist and cancer biologist is to identify novel targets for cancer therapy. Please confirm when setting up your appointment. Greater Boston Area. </p> <p>- Providers who are "accepting new patients" are able to book new patient appointments within 90 days. (617) 632–4245, Project:  Novel Therapeutic Targets and Mechanisms in T-cell Lymphomas, Copyright 2016 | Privacy policy | Legal statements     Call us: 617-632-3000, Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. © 2020 Mass General Brigham Incorporated. Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Project: Multi-dimensional characterization of lymphoma using single-cell sequencing, high-plex imaging and biophysical measurements to model the tumor microenvironment and identify novel therapeutic targets. Dr. Van Allen is an Associate Professor of Medicine at Harvard Medical School, a clinician at Dana-Farber/Partners Cancer Care, and an Associate Member at the Broad Institute of MIT and Harvard. "Accepting new patients" is subject to change. Board Certification, Medical Oncology, 2018, Board Certification, Internal Medicine, 2015. - A primary care provider (or PCP) is a doctor or in some cases, a nurse practitioner or physician assistant, who sees patients for everyday medical issues, such as colds and annual wellness visits. You may request a. </p> <p>Please confirm when setting up your appointment. Dana-Farber assumes no liability for inaccuracies that may result from using this third-party tool, which is for website translation and not clinical interactions. Project: characterizing minimal residual disease using Pick-seq and the tumor microenvironment using high-plex imaging, Focus: Defining vulnerabilities of minimal residual disease (MRD) in B-cell lymphomas, Project: Novel Targets in T-cell Lymphoma, Projects: Novel Therapeutic Targets in ALL We previously found that TBK1, a kinase that is normally involved in immune cell signaling, prevents apoptosis in cancer cells driven by oncogenic KRAS. Genet Epidemiol. Professor David R. Liu ~ Richard Merkin Professor and Director of the Merkin Institute of Transformative Technologies in Healthcare ~ Broad Institute Core Institute Member and Vice-Chair of the Faculty ~ Director of the Chemical Biology and Therapeutic Sciences Program ~ …     450 Brookline Avenue, Boston, MA 02215
 (650) 224-0183ssjain@bidmc.harvard.edu, Project: : T-cell lymphoma characterization via nascent transcriptomic sequencing, Projects: Novel Therapeutic Targets, Drug Resistance of Type II JAK2 Inhibition, Projects: Mouse Models of ALL, Experimental Therapeutics in Xenograft Models Please confirm when setting up your appointment. Recipes, discoveries, workshops, stories of hope and triumph can be found in the pages of Spotlight, Dana-Farber’s free digital newsletters. Samuel_Ng@DFCI.HARVARD.EDU Ajit Nirmal, PhD Project: Multi-dimensional characterization of lymphoma using single-cell sequencing, high-plex imaging and biophysical measurements to model the tumor microenvironment and identify novel therapeutic targets. - Providers may accept more insurance plans than shown. Dr. Liu is a medical oncologist and computational biologist at the Dana-Farber Cancer Institute and Brigham & Women's Hospital, with a background in computer science, biostatistics, and epidemiology. </p> <p>Patients can opt into this "direct primary care" model with an annual membership fee. </p> <p>David Liu Assistant Professor, DFCI, HMS Boston, Massachusetts 266 connections. My overall goal is to continue this effort clinically and in the lab to refine combination therapy for KRAS-driven lung cancer and improve outcomes for this challenging disease. - Primary Care providers who have "near-term availability" can book new patient appointments within 30 days. You may request a live medical interpreter for a discussion about your care. NOTES:    Site developed by Health Communication Core. Associate Director of the Robert and Renée Belfer Center for Applied Cancer Research, Associate Professor of Medicine, Harvard Medical School, Dana-Farber/Partners CancerCare, Medical Oncology, Massachusetts General Hospital, Chief Resident in Internal Medicine, Massachusetts General Hospital, Internal Medicine. - A primary care provider (or PCP) is a doctor or in some cases, a nurse practitioner or physician assistant, who sees patients for everyday medical issues, such as colds and annual wellness visits. Please call the practice to find out if your plan is accepted. Manager, Business Operations at Dana-Farber Cancer Institute. (617) 582–8866ALouissaint@partners.org, Projects: Novel Targets in T-cell Lymphomas, Mouse Models of T-cell Transformation 2020 Sep 14. </p>";s:7:"keyword";s:14:"david liu dfci";s:5:"links";s:3188:"<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-public-domain-lead-sheets'>Public Domain Lead Sheets</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-jd-sports-voucher'>Jd Sports Voucher</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-american-airlines-gold-status-benefits'>American Airlines Gold Status Benefits</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-scooby-doo-moon-monster-madness-shannon'>Scooby-doo Moon Monster Madness Shannon</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-jonny-briggs'>Jonny Briggs</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-dana-gourrier-django-unchained'>Dana Gourrier Django Unchained</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-international-monetary-fund-meaning'>International Monetary Fund Meaning</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-how-to-dry-ceiling-water-damage'>How To Dry Ceiling Water Damage</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-absolute-thai-charlestown-menu'>Absolute Thai Charlestown Menu</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-an-viet-dee-why'>An Viet Dee Why</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-tamarind-lounge'>Tamarind Lounge</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-ghana-vs-uruguay-2010-line-up'>Ghana Vs Uruguay 2010 Line Up</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-wwii-sites-in-southern-france'>Wwii Sites In Southern France</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-icd-10-paraplegia-with-neurogenic-bladder'>Icd-10 Paraplegia With Neurogenic Bladder</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-gabcikovo-nagymaros-case-necessity'>Gabcikovo-nagymaros Case Necessity</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-mediterraneo-restaurant-kampala'>Mediterraneo Restaurant Kampala</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-sammy-hagar-interview'>Sammy Hagar Interview</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-nightingale-yelp'>Nightingale Yelp</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-saudi-civil-war'>Saudi Civil War</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-no-water-coming-out-of-new-faucet'>No Water Coming Out Of New Faucet</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-ifc-capital'>Ifc Capital</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-station-52-restaurant-menu'>Station 52 Restaurant Menu</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-brownmark-instagram'>Brownmark Instagram</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-genesis-global-uk'>Genesis Global Uk</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-new-development-bank-members'>New Development Bank Members</a>,
<a href='https://africarisk.net/.tmb/docs/cxqkrdv.php?id=8cc357-ensuing-month-meaning'>Ensuing Month Meaning</a>,
";s:7:"expired";i:-1;}